Since the time of the patient’s initial testing, the DNAJC12 gene has been added to this panel; however, it is unclear if all babies with hyperphenylalaninemia undergo comprehensive molecular studies or even have access to this testing. This evidence concerns the gene DNAJC12 and Hyperphenylalaninemia.